These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30799029)

  • 1. Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.
    Lytvyn Y; Bjornstad P; Lovshin JA; Boulet G; Farooqi MA; Lai V; Tse J; Cham L; Lovblom LE; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Advani A; Sochett E; Perkins BA; Cherney DZI
    Am J Kidney Dis; 2019 Jun; 73(6):786-796. PubMed ID: 30799029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes.
    Lytvyn Y; Har R; Locke A; Lai V; Fong D; Advani A; Perkins BA; Cherney DZI
    Diabetes; 2017 Jul; 66(7):1939-1949. PubMed ID: 28408434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus.
    Cherney DZ; Reich HN; Miller JA; Lai V; Zinman B; Dekker MG; Bradley TJ; Scholey JW; Sochett EB
    Am J Physiol Regul Integr Comp Physiol; 2010 Jul; 299(1):R206-14. PubMed ID: 20410477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.
    Lytvyn Y; Bjornstad P; Lovshin JA; Singh SK; Boulet G; Farooqi MA; Lai V; Tse J; Cham L; Lovblom LE; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Advani A; Sochett E; Perkins BA; Cherney DZI
    Diabetes Obes Metab; 2019 Jun; 21(6):1388-1398. PubMed ID: 30761725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.
    Lovshin JA; Boulet G; Lytvyn Y; Lovblom LE; Bjornstad P; Farooqi MA; Lai V; Cham L; Tse J; Orszag A; Scarr D; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Perkins BA; Cherney DZ
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.
    Miller JA; Curtis JR; Sochett EB
    Diabetes; 2003 Jul; 52(7):1806-11. PubMed ID: 12829650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes.
    Škrtić M; Lytvyn Y; Bjornstad P; Reich HN; Scholey JW; Yip P; Sochett EB; Perkins B; Cherney DZ
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F599-F606. PubMed ID: 28031170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus.
    Yang GK; Maahs DM; Perkins BA; Cherney DZ
    PLoS One; 2013; 8(7):e68908. PubMed ID: 23861950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.
    Lovshin JA; Lytvyn Y; Lovblom LE; Katz A; Boulet G; Bjornstad P; Lai V; Cham L; Tse J; Orszag A; Keenan HA; Paul N; Bril V; Wong DT; McReelis KD; Brent MH; Perkins BA; Cherney DZI
    Diabetes Care; 2019 Feb; 42(2):273-280. PubMed ID: 30523033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.
    Bjornstad P; Lovshin JA; Lytvyn Y; Boulet G; Lovblom LE; Alhuzaim ON; Farooqi MA; Lai V; Tse J; Cham L; Orszag A; Scarr D; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Perkins BA; Cherney DZI
    Diabetes Care; 2018 Apr; 41(4):831-839. PubMed ID: 29437821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin-aldosterone system blockade in patients with advanced diabetic kidney disease.
    Bermejo S; García CO; Rodríguez E; Barrios C; Otero S; Mojal S; Pascual J; Soler MJ
    Nefrologia (Engl Ed); 2018; 38(2):197-206. PubMed ID: 29102270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease.
    Piani F; Reinicke T; Lytvyn Y; Melena I; Lovblom LE; Lai V; Tse J; Cham L; Orszag A; Perkins BA; Cherney DZI; Bjornstad P
    J Diabetes Complications; 2021 Mar; 35(3):107807. PubMed ID: 33288413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Profiles in Patients With Heart Failure.
    Lytvyn Y; Burns KD; Testani JM; Lytvyn A; Ambinathan JPN; Osuntokun O; Godoy LC; Cherney DZI; Parker JD
    J Card Fail; 2022 Mar; 28(3):385-393. PubMed ID: 34487814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.
    Miller JA
    J Am Soc Nephrol; 1999 Aug; 10(8):1778-85. PubMed ID: 10446946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function.
    van Bommel EJM; Ruiter D; Muskiet MHA; van Baar MJB; Kramer MHH; Nieuwdorp M; Joles JA; Bjornstad P; van Raalte DH
    Diabetes Care; 2020 Jan; 43(1):228-234. PubMed ID: 31662305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.
    Sochett EB; Cherney DZ; Curtis JR; Dekker MG; Scholey JW; Miller JA
    J Am Soc Nephrol; 2006 Jun; 17(6):1703-9. PubMed ID: 16672313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
    Cherney DZ; Perkins BA; Soleymanlou N; Maione M; Lai V; Lee A; Fagan NM; Woerle HJ; Johansen OE; Broedl UC; von Eynatten M
    Circulation; 2014 Feb; 129(5):587-97. PubMed ID: 24334175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus.
    Hollenberg NK; Price DA; Fisher ND; Lansang MC; Perkins B; Gordon MS; Williams GH; Laffel LM
    Kidney Int; 2003 Jan; 63(1):172-8. PubMed ID: 12472780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.